GLENN FERNANDES: Open Payments
NPI 1841356441 · CRESTVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 18 payments from 9 companies in 2025. Trend: 2023 $1,367 · 2024 $1,991 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $150 |
| ABBVIE INC. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 4 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: Ozempic, RINVOQ, XELJANZ, VOQUEZNA, ZENPEP, OMVOH, DUPIXENT, IBSRELA.
Industry payments across FL — which companies pay providers there.
